Male Breast Carcinoma Active Not Recruiting Phase 3 Trials for Bevacizumab (DB00112)

IndicationStatusPhase
DBCOND0030384 (Male Breast Carcinoma)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00785291Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast CancerTreatment
NCT00433511Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast CancerTreatment